P Matchaba  has been Global Head of Corporate Responsibility for Novartis since October 1, 2017. Dr. Matchaba most recently served as Global Head of the Cardio-Metabolic development unit at Novartis, where he led the global clinical development of the cardio-metabolic portfolio. He joined Novartis South Africa in 2000 as the Country Pharma Organization Chief Scientific Officer. Since moving to Novartis Pharmaceuticals Corporation in the United States in 2002, he has held several roles of increasing responsibility such as Therapeutic Area Head for Immunology and Infectious Diseases; Global Head of Drug Safety and Epidemiology; and Global Head of the Integrated Development Functions and Regions, which include Global Clinical Operations, Global Clinical Submissions, Integrated Information Sciences, Development Informatics, Development Diversity and Inclusion, and all Medical Country Pharma Organization regions. P Matchaba  has been Global Head of Corporate Responsibility for Novartis since October 1, 2017. Dr. Matchaba most recently served as Global Head of the Cardio-Metabolic development unit at Novartis, where he led the global clinical development of the cardio-metabolic portfolio. He joined Novartis South Africa in 2000 as the Country Pharma Organization Chief Scientific Officer. Since moving to Novartis Pharmaceuticals Corporation in the United States in 2002, he has held several roles of increasing responsibility such as Therapeutic Area Head for Immunology and Infectious Diseases; Global Head of Drug Safety and Epidemiology; and Global Head of the Integrated Development Functions and Regions, which include Global Clinical Operations, Global Clinical Submissions, Integrated Information Sciences, Development Informatics, Development Diversity and Inclusion, and all Medical Country Pharma Organization regions.

Pharmaceutical Industry